发明名称 |
andret stamme af den modificerede Vacciniavirus Ankara (MVA) |
摘要 |
The invention provides new strains of the Modified Vaccinia Virus Ankara (MVA) that have a strongly reduced virulence for most mammals, especially humans, but nevertheless grows in cells of a continuous cell line approved for the production of a therapeutic agent such as a vaccine. The invention also provides a method for producing said adapted MVA strains. The adapted MVA can be used e.g. for parenteral immunization, as a vector system, or in the active or inactivated from as an adjuvant or as a regulator of the unspecific components of the immune system. |
申请公布号 |
DK1263936(T3) |
申请公布日期 |
2006.02.13 |
申请号 |
DK20010931508T |
申请日期 |
2001.03.10 |
申请人 |
BAVARIAN NORDIC A/S |
发明人 |
MAYR, ANTON, PROF.DR.DR.H.C.MULT. |
分类号 |
A61K48/00;A61K35/76;A61K39/275;A61K39/39;A61P31/20;C12N7/08;C12N15/863 |
主分类号 |
A61K48/00 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|